View More Recent Stories

Aug 9, 2021 08:00AM Biocept to Report Second Quarter 2021 Financial Results and Host Investor Conference Call on August 16, 2021
Aug 3, 2021 08:17AM Biocept Names David Karlander as Senior Vice President of Commercial Operations
Jul 21, 2021 08:22AM Biocept (BIOC) Announces Medicare Issues Local Coverage Determination for Target Selector Breast Cancer Assay to Detect the HER2 Biomarker from Circulating Tumor Cells
Jul 21, 2021 08:17AM Medicare Issues Local Coverage Determination for Biocept’s Target Selector™ Breast Cancer Assay to Detect the HER2 Biomarker from Circulating Tumor Cells
Jul 20, 2021 08:17AM Biocept (BIOC) Welcomes Linda Rubinstein and Antonino Morales to Board of Directors, Names Director Samuel Riccitelli as Chairman
Jul 20, 2021 08:17AM Biocept Welcomes Linda Rubinstein and Antonino Morales to Board of Directors, Names Director Samuel Riccitelli as Chairman
Jul 19, 2021 08:00AM Biocept to Participate in Two July Investment Conferences
Jul 6, 2021 08:27AM Biocept (BIOC) Receives South Korean Patent for Primer-Switch Platform Used to Identify Rare Genetic Mutations, Including Cancer Biomarkers
Jul 6, 2021 08:27AM Biocept Receives South Korean Patent for Primer-Switch Platform Used to Identify Rare Genetic Mutations, Including Cancer Biomarkers
Jun 28, 2021 08:05AM Biocept Joins the Russell Microcap® Index
Jun 22, 2021 08:17AM Biocept (BIOC) to Collaborate with Quest Diagnostics (DGX) to Provide Advanced NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer
Jun 22, 2021 08:17AM Biocept to Collaborate with Quest Diagnostics to Provide Advanced NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer
Jun 15, 2021 08:17AM Biocept Receives More Than 420,000 Samples During First Year of Offering COVID-19 Testing Service
Jun 9, 2021 08:37AM Biocept and CLEARED4 Collaborate to Develop New Service for Managing COVID-19 Testing and Results Reporting for Biocept Customers
Jun 3, 2021 08:00AM Biocept to Present at the LD Micro Virtual Invitational XI Conference on June 9, 2021
Jun 2, 2021 04:05PM Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 12, 2021 04:05PM Biocept Reports First Quarter 2021 Financial Results
May 5, 2021 08:00AM Biocept to Report First Quarter 2021 Financial Results and Host Investor Conference Call on May 12, 2021
Apr 28, 2021 08:17AM Biocept to Supply COVID-19 Testing Through Partnership With the Foundation for California Community Colleges
Apr 21, 2021 08:17AM Biocept (BIOC) Announces Full Commercial Launch of CNSide Cerebrospinal Fluid Assay to Address Unmet Needs for Patients with Metastatic Brain Cancer
Apr 21, 2021 08:17AM Biocept Announces Full Commercial Launch of CNSide™ Cerebrospinal Fluid Assay to Address Unmet Needs for Patients with Metastatic Brain Cancer
Apr 14, 2021 08:05AM Biocept Provides Update on COVID-19 Testing with More than 350,000 Samples Received to Date
Apr 7, 2021 04:05PM Biocept to Host Key Opinion Leader Webinar to Discuss Its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System
Apr 1, 2021 05:00PM Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 1, 2021 08:05AM Biocept to Host Key Opinion Leader Webinar on April 8 to Discuss its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System
Mar 29, 2021 04:05PM Biocept Reports 2020 Fourth Quarter and Full Year Financial Results
Mar 22, 2021 08:00AM Biocept to Report 2020 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 29, 2021
Mar 9, 2021 07:00AM Biocept to Participate in Three Virtual Investment Conferences in March
Mar 3, 2021 04:05PM Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 2, 2021 08:11AM Aegea Biotechnologies Announces Supply Agreement with Biocept (BIOC) for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral Loa
Mar 2, 2021 08:07AM Aegea Biotechnologies Announces Supply Agreement with Biocept for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral Load
Mar 2, 2021 08:07AM Aegea Biotechnologies Announces Supply Agreement with Biocept for New COVID-19 Test with the Ability to Distinguish Virus Strains and Quantify Viral Load
Feb 23, 2021 08:17AM Biocept (BIOC) and Protean BioDiagnostics Establish Research Collaboration to Demonstrate Advantages of Biocept’s Target Selector Assay Kit for Non-Small Cell Lung Cancer Patients
Feb 23, 2021 08:07AM Biocept and Protean BioDiagnostics Establish Research Collaboration to Demonstrate Advantages of Biocept’s Target Selector™ Assay Kit for Non-Small Cell Lung Cancer Patients
Feb 16, 2021 08:11AM Biocept (BIOC) Announces Study Shows its Target Selector Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients
Feb 16, 2021 08:00AM Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients
Mar 2, 2020 09:24AM Pre-Open Stock Movers 03/02: (FTSV) (TRIL) (TWTR) Higher; (BIOC) (ENLV) (NVAX) Lower (more...)
Mar 14, 2017 08:12AM Biocept (BIOC) Enters Collaboration to Provide Liquid Biopsy Testing for Small Cell Lung Cancer Patients with Lambert Eaton Myasthenic Syndrome (LEMS)
Mar 14, 2017 08:05AM Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer to Patients with Lambert Eaton Myasthenic Syndrome (LEMS)
Feb 29, 2016 07:51AM Biocept (BIOC) Enters Agreement with PPO Network Prime Health Services
Feb 29, 2016 07:00AM Biocept Secures Agreement with Preferred Provider Organization Prime Health Services
Feb 6, 2015 01:25PM Unusual 11 Mid-Day Movers 2/6: (XLS) (ATV) (CBM) Higher; (RENT) (NKA) (ATNM) Lower
View More Recent Stories